Inventor · disambiguated record
Michael N. Dudley
Also filed as: DUDLEY MICHAEL N
37 granted patents·14 pending applications·317 citations·filing 1995–2024
98Inventor score
Files withREMPEX PHARMACEUTICALS INC13HORIZON ORPHAN LLC10MELINTA SUBSIDIARY CORP10MPEX PHARMACEUTICALS INC4RAPTOR PHARMACEUTICALS INC3
Top patents by PatentIndex Score
51 records- 0197US9694025B2Cyclic boronic acid ester derivatives and therapeutic uses thereofREMPEX PHARMACEUTICALS INC·Filed 2016·Granted Jul 4, 2017·21 cites·14 claims
- 0296US10004758B2Cyclic boronic acid ester derivatives and methods of making the sameREMPEX PHARMACEUTICALS INC·Filed 2017·Granted Jun 26, 2018·18 cites·30 claims
- 0396US9296763B2Cyclic boronic acid ester derivatives and therapeutic uses thereofREMPEX PHARMACEUTICALS INC·Filed 2013·Granted Mar 29, 2016·27 cites·24 claims
- 0496US8680136B2Cyclic boronic acid ester derivatives and therapeutic uses thereofHIRST GAVIN·Filed 2011·Granted Mar 25, 2014·69 cites·27 claims
- 0595US11090319B2Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivativesMELINTA SUBSIDIARY CORP·Filed 2020·Granted Aug 17, 2021·3 cites·9 claims
- 0694US8357696B2Aerosolized fluoroquinolones and uses thereofMPEX PHARMACEUTICALS INC·Filed 2010·Granted Jan 22, 2013·20 cites·43 claims
- 0794US7838532B2Aerosolized fluoroquinolones and uses thereofMPEX PHARMACEUTICALS INC·Filed 2006·Granted Nov 23, 2010·34 cites·84 claims
- 0893US10639318B2Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivativesREMPEX PHARMACEUTICALS INC·Filed 2018·Granted May 5, 2020·3 cites·21 claims
- 0993US10183034B2Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivativesREMPEX PHARMACEUTICALS INC·Filed 2018·Granted Jan 22, 2019·7 cites·29 claims
- 1093US10172874B2Pharmaceutical compositions comprising cyclic boronic acid ester derivativesREMPEX PHARMACEUTICALS INC·Filed 2018·Granted Jan 8, 2019·7 cites·24 claims
- 1192US8524734B2Aerosolized fluoroquinolones and uses thereofSURBER MARK W·Filed 2009·Granted Sep 3, 2013·13 cites·39 claims
- 1292US2025064838A1Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivativesMELINTA SUBSIDIARY CORP·Filed 2024·Application pending·0 cites
- 1391US8815838B2Aerosol fluoroquinolone formulations for improved pharmacokineticsGRIFFITH DAVID C·Filed 2009·Granted Aug 26, 2014·18 cites·80 claims
- 1491US8546423B2Aerosolized fluoroquinolones and uses thereofSURBER MARK W·Filed 2009·Granted Oct 1, 2013·12 cites·41 claims
- 1590US12161656B2Tetracycline compositionsMELINTA SUBSIDIARY CORP·Filed 2024·Granted Dec 10, 2024·0 cites·30 claims
- 1690US9717738B2Aerosol fluoroquinolone formulations for improved pharmacokineticsRAPTOR PHARMACEUTICALS INC·Filed 2016·Granted Aug 1, 2017·6 cites·29 claims
- 1790US8524735B2Aerosolized fluoroquinolones and uses thereofSURBER MARK W·Filed 2009·Granted Sep 3, 2013·10 cites·16 claims
- 1890US2025049820A1Tetracycline compositionsMELINTA SUBSIDIARY CORP·Filed 2024·Application pending·0 cites
- 1988US12171772B2Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivativesMELINTA SUBSIDIARY CORP·Filed 2023·Granted Dec 24, 2024·0 cites·5 claims
- 2088US9326936B2Aerosol fluoroquinolone formulations for improved pharmacokineticsRAPTOR PHARMACEUTICALS INC·Filed 2014·Granted May 3, 2016·7 cites·17 claims
- 2187US10987357B2Aerosolized fluoroquinolones and uses thereofHORIZON ORPHAN LLC·Filed 2019·Granted Apr 27, 2021·1 cites·13 claims
- 2287US10792289B2Use of aerosolized levofloxacin for treating cystic fibrosisHORIZON ORPHAN LLC·Filed 2019·Granted Oct 6, 2020·2 cites·8 claims
- 2387US9278105B2Tetracycline compositionsREMPEX PHARMACEUTICALS INC·Filed 2012·Granted Mar 8, 2016·6 cites·60 claims
- 2485US10231975B2Use of aerosolized levofloxacin for treating cystic fibrosisHORIZON ORPHAN LLC·Filed 2017·Granted Mar 19, 2019·4 cites·20 claims
- 2584US10149854B2Aerosol fluoroquinolone formulations for improved pharmacokineticsHORIZON ORPHAN LLC·Filed 2017·Granted Dec 11, 2018·2 cites·20 claims
- 2684US8629139B2Topical use of Levofloxacin for reducing lung inflammationDUDLEY MICHAEL N·Filed 2009·Granted Jan 14, 2014·10 cites·47 claims
- 2782US10722519B2Aerosol fluoroquinolone formulations for improved pharmacokineticsHORIZON ORPHAN LLC·Filed 2018·Granted Jul 28, 2020·1 cites·10 claims
- 2882US9084802B2Tetracycline compositionsREMPEX PHARMACEUTICALS INC·Filed 2014·Granted Jul 21, 2015·3 cites·31 claims
- 2980US11684629B2Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivativesMELINTA SUBSIDIARY CORP·Filed 2021·Granted Jun 27, 2023·0 cites·5 claims
- 3080US11376237B2Methods of treating bacterial infectionsMELINTA SUBSIDIARY CORP·Filed 2018·Granted Jul 5, 2022·2 cites·20 claims
- 3179US9700564B2Use of aerosolized levofloxacin for treating cystic fibrosisLOUTIT JEFFERY S·Filed 2012·Granted Jul 11, 2017·6 cites·24 claims
- 3277US11944634B2Tetracycline compositionsMELINTA SUBSIDIARY CORP·Filed 2019·Granted Apr 2, 2024·0 cites·25 claims
- 3376US10561675B2Cyclic boronic acid ester derivatives and therapeutic uses thereofREMPEX PHARMACEUTICALS INC·Filed 2013·Granted Feb 18, 2020·2 cites·14 claims
- 3472US2021121472A1Aerosol fluoroquinolone formulations for improved pharmacokineticsHORIZON ORPHAN LLC·Filed 2020·Application pending·0 cites
- 3570US2022080047A1Topical use of levofloxacin for reducing lung inflammationHORIZON ORPHAN LLC·Filed 2021·Application pending·0 cites
- 3668US9744179B2Tetracycline compositionsREMPEX PHARMACEUTICALS INC·Filed 2014·Granted Aug 29, 2017·0 cites·32 claims
- 3767US11020481B2Topical use of levofloxacin for reducing lung inflammationHORIZON ORPHAN LLC·Filed 2017·Granted Jun 1, 2021·0 cites·5 claims
- 3867US2021228589A1Use of aerosolized levofloxacin for treating cystic fibrosisHORIZON ORPHAN LLC·Filed 2020·Application pending·0 cites
- 3966US11007206B2Cyclic boronic acid ester derivatives and therapeutic uses thereofMELINTA SUBSIDIARY CORP·Filed 2020·Granted May 18, 2021·0 cites·20 claims
- 4064US2018078570A1Tetracycline compositionsREMPEX PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 4163US2014066441A1Aerosolized fluoroquinolones and uses thereofMPEX PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 4261US2016279138A1Aerosolized fluoroquinolones and uses thereofRAPTOR PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4358US2014105985A1Topical use of levofloxacin for reducing lung inflammationMPEX PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 4457US2019105337A1Methods of treating bacterial infectionsREMPEX PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4556US2022047604A1Aerosolized fluoroquinolones and uses thereofHORIZON ORPHAN LLC·Filed 2021·Application pending·0 cites
- 4653US12478606B2Methods of treating bacterial infectionsMELINTA SUBSIDIARY CORP·Filed 2018·Granted Nov 25, 2025·0 cites·69 claims
- 4750US2015119363A1Methods of treating bacterial infectionsRAMPEX PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 4850US2016339045A1Methods of treating bacterial infectionsREMPEX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4934US2012237564A1Use of Aerosolized Antibiotics for Treating Chronic Obstructive Pulmonary DiseaseDUDLEY MICHAEL N·Filed 2012·Application pending·0 cites
- 5026US5728576AIn vitro cover slip suspension moduleRHODE ISLAND EDUCATION·Filed 1996·Granted Mar 17, 1998·3 cites·9 claims
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael N. Dudley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →